Intermediate-dose Cytarabine Protocol

Curated Five Minute Hematology reference for Intermediate-dose Cytarabine. Open the approved protocol in 5MH Tools.

Acute Myeloid Leukemia Treatment regimen

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Protocol reference Intermediate-dose Cytarabine · Acute Myeloid Leukemia · Treatment regimen · v1.2.1
Aliases IDAC, intermediate dose cytarabine
Medical review Reviewed 2026-10-07 · Every 28 days or after bone marrow recovery; meet the documented recovery criteria before another course.
Protocol type Defined multi-drug regimen with a specified treatment schedule.
Source transparency Evidence references are available in the approved 5MH protocol.